Ask HopeStage to review this study with me
Study ID: NCT03920475. We help you review the study, but cannot decide medical eligibility.
CompletedNCT03920475
Investigation of the Role of Inflammatory Processes in the Development and Treatment of Idiopathic Unipolar and Depression for depression in bipolarity
This study is completed. It focuses on depression in bipolarity.
Depression, InflammationDrugFrom 18 Years to 65 Years
Key information made simple
This summary needs review. Please check the official study record and contact the research team for details.
Your next step
The official record does not clearly spell out the visit format, but it appears to be coordinated directly by the research team. Participation appears to center on assessments, scans, or samples rather than trying a new treatment. The main fit is usually matching the main diagnosis, while common reasons not to take part include major medical issues that could make participation unsuitable and active substance or alcohol problems that could affect the results. The official record does not list a trial phase, which usually means the study is focused on observation rather than testing a staged treatment.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateStarted: August 5, 2015
- Recruitment status
- Completed
- Estimated enrollment
- Not clearly listed
- Sponsor
- Kliniken Essen-Mitte
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- Not clearly listed
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT03920475
- Official title
- An Investigation of the Role of Inflammatory Processes in the Development and Treatment of Idiopathic Unipolar and Bipolar Depression in Patients With Moderate to Severe Depressive Symptoms.
- Official source
- Official registry link
Want help reviewing this study?
Study ID: NCT03920475. We help you review the study, but cannot decide medical eligibility.
For you
Taking part may give access to a new approach being evaluated.
It requires regular follow-up, often through questionnaires or interviews.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring behavioral or lifestyle intervention for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study. The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.
Do I need to want to stop or reduce tobacco use to participate?
The public registry appears to mention tobacco, nicotine, alcohol, cannabis, or another addiction-related topic. Ask the study team whether you need to want to stop, reduce, already be abstinent, or simply meet use-related criteria. Eligibility must be confirmed by the study team.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
What practical constraints should I expect?
The likely practical burden appears high. Things to check include long follow-up or multiple visits, medical follow-up. Ask the study team about duration, visits, possible compensation, data access, and what happens if you want to stop.
Who is behind this study?
This study is sponsored by Kliniken Essen-Mitte, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The registry indicates that this study is completed. It may still be useful for understanding the research, but you are unlikely to be able to join.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT06432322
(GluEsk) Glutamate and Esketamine
This study is completed. It focuses on depression and currently lists study information in the United Kingdom.
CompletedNCT00223496
12- Week Open Label Treatment of Refractory Depression in bipolarity
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
CompletedNCT02363738
12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression
This study is completed. It focuses on bipolarity and currently lists study information in Canada and the United States.